ASCT May Offer Alternative for Tx of High-Risk Follicular Lymphoma

THURSDAY, July 25, 2019 -- Autologous stem cell transplantation (ASCT) may be an effective treatment option in high-risk, early therapy failure (ETF) follicular lymphoma (FL), prior to the use of rituximab, according to a study published online July...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news